Nanosonics: ASX Spotlight Presentation 2014

Company Presentations

Nanosonics Limited (ASX:NAN) CEO & President Michael Kavanagh presents at ASX Spotlight London about the company’s technology development for the infection control market.

Focused on both patient safety, but also risk mitigation for clinical workers, Nanosonics has achieved approvals in Australia, Europe and the US for its Trophon EPR sterilisation equipment. GE Healthcare has come on board as sole US distributor.

In an environment where hospital acquired infection from ultrasound probes is an increasing problem, Nanosonic's Trophon EPR unit offers a non-toxic, rapid and modern sterilisation options for trans-cavity probe units.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?